SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 216 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $607,000 | +5.4% | 17,325 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $576,000 | -51.3% | 17,325 | -26.2% | 0.01% | -46.7% |
| Q3 2018 | $1,182,000 | -29.6% | 23,473 | -16.3% | 0.02% | -34.8% |
| Q2 2018 | $1,679,000 | -3.5% | 28,058 | -26.1% | 0.02% | -14.8% |
| Q1 2018 | $1,739,000 | -33.5% | 37,966 | -42.1% | 0.03% | -28.9% |
| Q4 2017 | $2,614,000 | -8.2% | 65,600 | -7.8% | 0.04% | -5.0% |
| Q3 2017 | $2,846,000 | -7.9% | 71,143 | -0.7% | 0.04% | -14.9% |
| Q2 2017 | $3,089,000 | -27.6% | 71,670 | -47.4% | 0.05% | -34.7% |
| Q1 2017 | $4,265,000 | +64.0% | 136,272 | +32.3% | 0.07% | +44.0% |
| Q4 2016 | $2,601,000 | -14.5% | 103,000 | -16.3% | 0.05% | -7.4% |
| Q3 2016 | $3,042,000 | +21.4% | 123,000 | 0.0% | 0.05% | +12.5% |
| Q2 2016 | $2,506,000 | -31.0% | 123,000 | -48.3% | 0.05% | -31.4% |
| Q1 2016 | $3,630,000 | +13.5% | 238,000 | 0.0% | 0.07% | +25.0% |
| Q4 2015 | $3,199,000 | -21.4% | 238,000 | -17.9% | 0.06% | -17.6% |
| Q3 2015 | $4,069,000 | -58.7% | 290,000 | -50.0% | 0.07% | -2.9% |
| Q2 2015 | $9,848,000 | +114.4% | 580,000 | +52.6% | 0.07% | +6.1% |
| Q1 2015 | $4,594,000 | +325.8% | 380,000 | +192.3% | 0.07% | +312.5% |
| Q4 2014 | $1,079,000 | – | 130,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $17,478,000 | 3.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,124,405 | $36,341,000 | 3.91% |
| ARMISTICE CAPITAL, LLC | 3,100,000 | $100,192,000 | 1.94% |
| S&T BANK/PA | 316,326 | $10,224,000 | 1.54% |
| Bruce & Co., Inc. | 222,105 | $7,178,000 | 1.47% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 379,875 | $12,278,000 | 1.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 854,949 | $27,632,000 | 1.10% |
| Soleus Capital Management, L.P. | 251,000 | $8,112,000 | 1.05% |
| Parkman Healthcare Partners LLC | 108,954 | $3,521,000 | 1.03% |
| Aristotle Capital Boston, LLC | 1,258,067 | $40,661,000 | 1.03% |